(Q37098529)

18 August 2017

1 reference

title

Systemic allergic contact dermatitis from intravesical instillation of the antitumor antibiotic mitomycin C (English)

1 reference

https://api.crossref.org/works/10.1111/J.1600-0536.1991.TB01699.X

allergic contact dermatitis

4 December 2022

main subject

antibiotic

0 references

1 reference

1 reference

https://api.crossref.org/works/10.1111/J.1600-0536.1991.TB01699.X

4 December 2022

author name string

A. C. de Groot

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1831098

4 December 2022

J. M. Conemans

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1831098

4 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1831098

4 December 2022

publication date

1 March 1991

1 reference

full work available at URL

18 August 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1600-0536.1991.tb01699.x

1 reference

https://api.crossref.org/works/10.1111/J.1600-0536.1991.TB01699.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0536.1991.tb01699.x/fullpdf

4 December 2022

1 reference

https://api.crossref.org/works/10.1111/J.1600-0536.1991.TB01699.X

4 December 2022

1 reference

18 August 2017

volume

24

1 reference

18 August 2017

issue

3

1 reference

18 August 2017

page(s)

201-209

1 reference

Dermatitis Due to Mitomycin Bladder Instillations

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0536.1991.TB01699.X

Dermatitis due to intravesical mitomycin C: a delayed-type hypersensitivity reaction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0536.1991.TB01699.X

Doxorubicin plus mitomycin C regimen in the prophylactic treatment of superficial bladder tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0536.1991.TB01699.X

Mitomycin C intravesical therapy in noninvasive bladder cancer after failure on thiotepa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0536.1991.TB01699.X

A phase II study of intravesical mitomycin C in the treatment of superficial bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0536.1991.TB01699.X

The baboon syndrome: systemically-induced allergic contact dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0536.1991.TB01699.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0536.1991.TB01699.X

Carcinoma in situ of the urinary bladder. Effect of associated neoplastic lesions on clinical course and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0536.1991.TB01699.X

Mitomycin C resorption following repeated intravesical instillations using different instillation times

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0536.1991.TB01699.X

Intravesical mitomycin C therapy for superficial bladder cancer. Report of a multicentre phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0536.1991.TB01699.X

Role of intravesical mitomycin C in management of superficial bladder tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0536.1991.TB01699.X

Intravesical mitomycin C for the treatment of recurrent superficial bladder tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0536.1991.TB01699.X

Intravesical instillation of mitomycin C in the prophylactic treatment of recurring superficial transitional cell carcinoma of the bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0536.1991.TB01699.X

Allergy to mitomycin C complicating topical administration for urothelial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0536.1991.TB01699.X

Behavior and resorption of mitomycin C following multiple intravesical administrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0536.1991.TB01699.X

Skin rash following therapy with mitomycin C

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0536.1991.TB01699.X

Erythroderma from systemic contact dermatitis: a complication of systemic gentamicin in a patient with contact allergy to neomycin

21 January 2018

2

1 reference

https://api.crossref.org/works/10.1111/J.1600-0536.1991.TB01699.X

Side effects associated with intravesical mitomycin

4 December 2022

4

1 reference

https://api.crossref.org/works/10.1111/J.1600-0536.1991.TB01699.X

Intravesical mitomycin C instillation as a prophylactic treatment of superficial bladder tumor.

4 December 2022

11

1 reference

https://api.crossref.org/works/10.1111/J.1600-0536.1991.TB01699.X

Effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: interim report from the Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party).

4 December 2022

14

1 reference

https://api.crossref.org/works/10.1111/J.1600-0536.1991.TB01699.X

The outcome of conservative treatment of carcinoma in situ of the bladder.

4 December 2022

15

1 reference

https://api.crossref.org/works/10.1111/J.1600-0536.1991.TB01699.X

Mitomycin C Bladder Instillation Therapy for Bladder Tumors

4 December 2022

17

1 reference

https://api.crossref.org/works/10.1111/J.1600-0536.1991.TB01699.X

Topical mitomycin C therapy for carcinoma of the bladder

4 December 2022

22

1 reference

https://api.crossref.org/works/10.1111/J.1600-0536.1991.TB01699.X

Intravesical Thiotepa versus Mitomycin C in Patients with TA, T1 and TIS Transitional Cell Carcinoma of the Bladder: A Phase III Prospective Randomized Study

4 December 2022

24

1 reference

https://api.crossref.org/works/10.1111/J.1600-0536.1991.TB01699.X

Cytostatic intravesical instillation in patients with superficial bladder carcinoma for the prevention of recurrent tumors

4 December 2022

26

1 reference

https://api.crossref.org/works/10.1111/J.1600-0536.1991.TB01699.X

Treatment of superficial bladder cancer with intravesical mitomycin C: analysis of immediate and long-term response in 70 patients

4 December 2022

27

1 reference

https://api.crossref.org/works/10.1111/J.1600-0536.1991.TB01699.X

Intravesical therapy of low stage bladder carcinoma with mitomycin C: comparison of results in untreated and previously treated patients.

4 December 2022

29

1 reference

https://api.crossref.org/works/10.1111/J.1600-0536.1991.TB01699.X

The effect of mitomycin C on superficial bladder cancer

4 December 2022

30

1 reference

https://api.crossref.org/works/10.1111/J.1600-0536.1991.TB01699.X

Effect of mitomycin C and doxorubicin instillation on carcinoma in situ of the urinary bladder. A Finnish multicenter study

4 December 2022

33

1 reference

https://api.crossref.org/works/10.1111/J.1600-0536.1991.TB01699.X

Adjuvant intravesical chemotherapy of superficial bladder cancer with monthly doxorubicin or intensive mitomycin. A comparison of two consecutive series

4 December 2022

34

1 reference

https://api.crossref.org/works/10.1111/J.1600-0536.1991.TB01699.X

A trial of prophylactic thiotepa or mitomycin C intravesical therapy in patients with recurrent or multiple superficial bladder cancers

4 December 2022

38

1 reference

https://api.crossref.org/works/10.1111/J.1600-0536.1991.TB01699.X

Intravesical combination chemotherapy with mitomycin C and doxorubicin for carcinoma in situ of the bladder

4 December 2022

39

1 reference

https://api.crossref.org/works/10.1111/J.1600-0536.1991.TB01699.X

Metaphylactic effect of mitomycin C with and without hyaluronidase after transurethral resection of bladder cancer: randomized trial

4 December 2022

40

1 reference

https://api.crossref.org/works/10.1111/J.1600-0536.1991.TB01699.X

Immunotherapy in bladder cancer with keyhole-limpet hemocyanin: a randomized study

4 December 2022

41

1 reference

https://api.crossref.org/works/10.1111/J.1600-0536.1991.TB01699.X

Topical mitomycin C therapy for carcinoma of the bladder

4 December 2022

42

1 reference

https://api.crossref.org/works/10.1111/J.1600-0536.1991.TB01699.X

Long-term mitomycin C instillation after transurethral resection of superficial bladder carcinoma: influence on recurrence, progression and survival

4 December 2022

46

1 reference

https://api.crossref.org/works/10.1111/J.1600-0536.1991.TB01699.X

4 December 2022

Identifiers

1 reference

18 August 2017

1 reference